Enliven Therapeutics, Inc. (ELVN) Ownership

$21.86

$2.72 (14.21%)
Last update: 04:00 PM EST
Day's range
$18.85
Day's range
$22.14

Enliven Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
ORBIMED ADVISORS LLC 05/15/2025 7.96 M $156.64 M   0.00% 15.96%
FMR LLC 05/12/2025 6.61 M $130.08 M   1.75% 13.21%
COMMODORE CAPITAL LP 05/15/2025 4.68 M $92.00 M   11.18% 9.38%
VR ADVISER, LLC 05/15/2025 4.03 M $79.24 M   0.00% 8.08%
FAIRMOUNT FUNDS MANAGEMENT LLC 05/15/2025 3.20 M $63.03 B   0.00% 6.40%
BLACKROCK, INC. 05/02/2025 3.00 M $59.00 M   1.11% 5.99%
POLAR CAPITAL HOLDINGS PLC 05/15/2025 2.37 M $46.55 M   -1.02% 4.73%
VANGUARD GROUP INC 05/09/2025 1.97 M $38.81 M   -0.17% 3.94%
JANUS HENDERSON GROUP PLC 05/15/2025 1.57 M $33.05 M   17.92% 3.14%
5AM VENTURE MANAGEMENT, LLC 05/15/2025 1.32 M $26.03 B   -18.85% 2.64%
CITADEL ADVISORS LLC 05/15/2025 1.12 M $22.10 M   -35.40% 2.24%
PICTET ASSET MANAGEMENT HOLDING SA 05/05/2025 967.50 K $19.04 M   -0.49% 1.93%
RA CAPITAL MANAGEMENT, L.P. 05/15/2025 848.99 K $16.71 M   0.00% 1.70%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 819.17 K $16.12 M   7.40% 1.64%
WOODLINE PARTNERS LP 05/15/2025 805.16 K $15.85 M   -0.09% 1.61%
STATE STREET CORP 05/15/2025 780.90 K $15.37 M   -2.61% 1.56%
BLACKSTONE INC. 05/15/2025 762.31 K $15.00 M   104.20% 1.52%
05/15/2025 671.36 K $13.21 B   0.00% 1.34%
FIRST TURN MANAGEMENT, LLC 05/15/2025 535.09 K $10.53 M   0.00% 1.07%
ROCK SPRINGS CAPITAL MANAGEMENT LP 05/15/2025 465.87 K $9.17 B   8.70% 0.93%
ADAGE CAPITAL PARTNERS GP, L.L.C. 05/15/2025 450.00 K $8.86 M   -30.77% 0.90%
NORTHERN TRUST CORP 05/13/2025 338.65 K $6.66 M   2.16% 0.68%
IKARIAN CAPITAL, LLC 05/15/2025 289.54 K $5.70 M   -26.61% 0.58%
ACUTA CAPITAL PARTNERS, LLC 05/15/2025 265.27 K $5.22 M   -0.79% 0.53%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 259.54 K $5.11 M   -0.90% 0.52%
PATIENT SQUARE CAPITAL LP 05/14/2025 253.84 K $5.00 M   13.30% 0.51%
CORMORANT ASSET MANAGEMENT, LP 05/15/2025 250.00 K $4.92 M   0.00% 0.50%
LOGOS GLOBAL MANAGEMENT LP 05/15/2025 240.00 K $4.72 B   71.43% 0.48%
GOLDMAN SACHS GROUP INC 05/16/2025 211.75 K $4.17 M   61.34% 0.42%
LORD, ABBETT & CO. LLC 05/13/2025 197.28 K $3.88 M   -48.92% 0.39%
ALLY BRIDGE GROUP (NY) LLC 05/15/2025 169.77 K $3.34 M   19.80% 0.34%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2025 139.92 K $2.75 M   100.00% 0.28%
MILLENNIUM MANAGEMENT LLC 05/15/2025 132.89 K $2.62 M   161.57% 0.27%
STEMPOINT CAPITAL LP 05/15/2025 120.43 K $2.37 M   24.52% 0.24%
BAKER BROS. ADVISORS LP 05/15/2025 114.83 K $2.26 M   0.00% 0.23%
HIGHVISTA STRATEGIES LLC 05/15/2025 112.46 K $2.21 M   0.00% 0.22%
SPHERA FUNDS MANAGEMENT LTD. 05/15/2025 111.74 K $2.20 M   100.00% 0.22%
RUSSELL INVESTMENTS GROUP, LTD. 05/13/2025 105.54 K $2.08 M   148,550.70% 0.21%
05/12/2025 104.10 K $2.05 M   100.00% 0.21%
BANK OF NEW YORK MELLON CORP 04/29/2025 93.57 K $1.84 M   4.46% 0.19%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 84.70 K $1.67 M   4.68% 0.17%
MORGAN STANLEY 05/15/2025 81.32 K $1.60 M   -26.48% 0.16%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2025 76.98 K $1.51 M   -26.61% 0.15%
FEDERATED HERMES, INC. 05/08/2025 69.05 K $1.36 M   -41.26% 0.14%
RHUMBLINE ADVISERS 05/29/2025 52.50 K $1.03 M   4.93% 0.10%
BARCLAYS PLC 05/15/2025 50.36 K $991.00 K   -22.00% 0.10%
STATE OF WISCONSIN INVESTMENT BOARD 05/15/2025 45.76 K $900.48 K   70.51% 0.09%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 44.92 K $883.93 K   189.21% 0.09%
SWISS NATIONAL BANK 05/12/2025 41.87 K $824.06 K   0.00% 0.08%
ALLIANCEBERNSTEIN L.P. 05/15/2025 36.84 K $725.01 K   0.00% 0.07%

Enliven Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 122 institutional investors and hedge funds held shares of Enliven Therapeutics, Inc.. The most heavily invested institutionals were:

ORBIMED ADVISORS LLC: 7.96 M

FMR LLC: 6.61 M

COMMODORE CAPITAL LP: 4.68 M

VR Adviser, LLC: 4.03 M

Fairmount Funds Management LLC: 3.2 M

BlackRock, Inc.: 3 M

99.67% of Enliven Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 52.45 M shares in the last 24 months. This purchase volume represents approximately $1.15 B in transactions.